Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 639587, 7 pages
http://dx.doi.org/10.1155/2015/639587
Research Article

Parathyroidectomy Is Associated with Reduced Mortality in Hemodialysis Patients with Secondary Hyperparathyroidism

1Department of Internal Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, 539 Jhongsiao Road, Chiayi 600, Taiwan
2Department of Applied Life Science and Health, Chia Nan University of Pharmacy and Science, No. 60, Section 1, Erren Road, Rende District, Tainan 71710, Taiwan
3Department of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, 1 University Road, Tainan 701, Taiwan
4Department of Occupational and Environmental Medicine, National Cheng Kung University Hospital, 138 Sheng Li Road, Tainan 704, Taiwan
5Department of Internal Medicine, National Taiwan University Hospital, 7 Chung Shan South Road, Zhongzheng District, Taipei City 10002, Taiwan

Received 9 February 2015; Revised 4 April 2015; Accepted 11 April 2015

Academic Editor: Michael Fröhner

Copyright © 2015 Tsung-Liang Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. H. Hörl, “The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes,” Nephrology Dialysis Transplantation, vol. 19, no. 5, pp. v2–v8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, “KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD–MBD),” Kidney International, vol. 76, supplement 113, pp. S1–S130, 2009. View at Google Scholar
  3. M. Fukagawa, K. Yokoyama, F. Koiwa et al., “Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder,” Therapeutic Apheresis and Dialysis, vol. 17, no. 3, pp. 247–288, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. National Kidney Foundation, “K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease,” American Journal of Kidney Disease, vol. 42, supplement 3, pp. S1–S202, 2003. View at Google Scholar
  5. S. M. Moe, G. M. Chertow, J. W. Coburn et al., “Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl,” Kidney International, vol. 67, no. 2, pp. 760–771, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. E. Charlson, P. Pompei, K. L. Ales, and C. R. MacKenzie, “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation,” Journal of Chronic Diseases, vol. 40, no. 5, pp. 373–383, 1987. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Amal and P. Bergmann, “Evaluation of a chemiluminescence immunoassay for the determination of intact parathyroid hormone using the ADVIA Centaur,” Clinical Laboratory, vol. 50, no. 11-12, pp. 695–702, 2004. View at Google Scholar · View at Scopus
  8. J. T. Daugirdas, “Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error,” Journal of the American Society of Nephrology, vol. 4, no. 5, pp. 1205–1213, 1993. View at Google Scholar · View at Scopus
  9. R. Schneider, E. P. Slater, E. Karakas, D. K. Bartsch, and K. Schlosser, “Initial parathyroid surgery in 606 patients with renal hyperparathyroidism,” World Journal of Surgery, vol. 36, no. 2, pp. 318–326, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Costa-Hong, V. Jorgetti, L. H. W. Gowdak, R. M. A. Moyses, E. M. Krieger, and J. J. G. De Lima, “Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism,” Surgery, vol. 142, no. 5, pp. 699–703, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Trombetti, C. Stoermann, J. H. Robert et al., “Survival after parathyroidectomy in patients with end-stage renal disease and severe hyperparathyroidism,” World Journal of Surgery, vol. 31, no. 5, pp. 1014–1021, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Sharma, P. Raggi, N. Kutner et al., “Improved long-term survival of dialysis patients after near-total parathyroidectomy,” Journal of the American College of Surgeons, vol. 214, no. 4, pp. 400–407, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Iwamoto, N. Sato, M. Nishida et al., “Total parathyroidectomy improves survival of hemodialysis patients with secondary hyperparathyroidism,” Journal of Nephrology, vol. 25, no. 5, pp. 755–763, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Komaba, M. Taniguchi, A. Wada, K. Iseki, Y. Tsubakihara, and M. Fukagawa, “Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism,” Kidney International, 2015. View at Publisher · View at Google Scholar
  15. A. Karamé, M. Labeeuw, P. Trolliet et al., “The impact of type 2 diabetes on mortality in end-stage renal disease patients differs between genders,” Nephron: Clinical Practice, vol. 112, no. 4, pp. c268–c275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. H. C. Lin, C. L. Chen, H. S. Lin et al., “Parathyroidectomy improves cardiovascular outcome in nondiabetic dialysis patients with secondary hyperparathyroidism,” Clinical Endocrinology, vol. 80, no. 4, pp. 508–515, 2014. View at Publisher · View at Google Scholar